Incubation of trypanosome-derived mitogenic and immunosuppressive products with peritoneal macrophages allows recovery of biological activities from soluble parasite fractions.
This report describes further attempts to define the nature of the parasite product(s) responsible for the extensive changes in lymphoid tissue in mice during infection with Trypanosoma brucei. As previously described, potent mitogenic and immunosuppressive effects are induced by a trypanosome-derived crude membrane fraction in vivo. There was no enrichment in these activities when purified parasite surface membranes were used. Mitogenic activity can be recovered from soluble trypanosome material only when it is incubated with peritoneal macrophages before transfer into syngeneic recipients. Thus, by encouraging association with a critical target cell, soluble parasite products can be studied, and their active components can be separated by conventional methods. Preliminary fractionation of high-spin trypanosome supernatant over Sepharose 4B confined the mitogenic activity to the high-molecular-weight fraction, which is a macromolecular complex of proteins, glycoproteins, and lipid. Extracted lipid from this material was able to significantly suppress a primary immunoglobulin G anti-sheep erythrocyte response. The activity was periodate sensitive and pronase resistant. The use of macrophages in vitro may be a general method whereby important biological activities lost as a result of fractionation procedures can be recovered and the active components studied in greater detail.
D000818:Animals; D000917:Antibody Formation; D001202:Ascitic Fluid / Q000166:cytology; D002462:Cell Membrane / Q000032:analysis; D005260:Female; D007166:Immunosuppressive Agents / Q000032:analysis*; D008055:Lipids / Q000032:analysis; D008264:Macrophages / Q000502:physiology*; D051379:Mice; D008934:Mitogens / Q000032:analysis*; D010504:Periodic Acid / Q000494:pharmacology; D011402:Pronase / Q000494:pharmacology; D011506:Proteins / Q000032:analysis; D014346:Trypanosoma brucei brucei / Q000032:analysis*
D007166:Immunosuppressive Agents; D008055:Lipids; D008934:Mitogens; D011506:Proteins; D010504:Periodic Acid; D011402:Pronase